Rasid, Mazidah Abdul
(2004)
Kedudukan hormon tumbesaran di kalangan pesakit talasemia.
Kedudukan hormon tumbesaran di kalangan pesakit talasemia.
(Submitted)
Abstract
Aim: The aim of this study is to compare the pattern of growth hormone secretion and serum IGF-1 in
children with transfusiop dependent thalassemia and normal children.
Method: Children aged 6-12 years with transfusion dependent thalassemia were randomly selected from
children with thalassemia admitted to University of Science Malaysia Hospital from October 1993 to
October 1995. None of the patients gave a family history of malnutrition, diabetes mellitus, dwarfism or
other endocrine diseases. Normal children volunteers were mainly healthy children of staff members in
the hospital.
The heights, bone age, serum ferritin and serum IGF-1 were measured in all the children. Serum growth
hormone was measured following stimulation with exercise and intravenous glucagon. Both serum
growth hormone and serum IGF-1 were estimated by radioimmunoassay using a double antibody.
Results: A total of 22 thalassemic children (4 P-thalassemia major and 18 HbEIP-thalassemia) and 10
normal children were studied. There was no difference in sex, mean chronological age and mean bone
age between thalassemic and..flprmal children. The Z-scores and serum ferritin were significantly more in
thalassemic than normal children. The serum thyroxine and thyroid stimulating hormone were normal in
both groups.
The mean peak serum growth hormone following exercise and intravenous glucagon was 4.2 ug/L and
3.8 ug!L in thalassemic children and 3.6 ug/L and 4.8 ug/L in normal children respectively. There were
not statistically significant. The mean serum IGF-1 levels was significantly higher (p = 0.001) in the
normal (25.5 ng/L) than the thalassemia children (12.3 ng/L). In thalassemia children there was no
correlation between serum ferritin and .age (r =- 0.04) and between serum ferritin level and serum IGF-1
levels (r = 0.01). There was only a weak negative correlation between serum ferritin and peak growth
hormone levels after exercise (r = - 0.30) and glucagon stimulation (r = - 0.29).
Conclusion: GH secretion, as evaluated by the responses to exercise and glucagon stimulation, is not
impaired, while the generation of serum IGF-1 is reduced in this group of thalassemic children.
Comparison of these data with those of other published reports indicate that impairment of GH secretion
may occur later in the course of the disease. A reduction in IGF-1 production probably secondary to
excessive iron deposition in the liver is manifested earlier. The presence of impaired IGF-1 production
may be a cause of short stature in these children. The achievement of relatively constant haemoglobin
levels and reduction of tissue iron stores with long term iron chelation therapy is needed to prevent these
endocrine abnormalities.
Actions (login required)
 |
View Item |
